Orthognathic surgery in patients treated with bisphosphonates: A case series
暂无分享,去创建一个
[1] E. Carlson,et al. American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaw-2022 Update. , 2022, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[2] Hyo-Jung Lee,et al. Gradual, but Not Sudden, Dose-Dependent Increase of ONJ Risk With Bisphosphonate Exposure: A Nationwide Cohort Study in Women With Osteoporosis , 2021, Frontiers in Endocrinology.
[3] A. Munz,et al. Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis. , 2021, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.
[4] J. Zöller,et al. Bisphosphonate application and volumetric effects on MRONJ lesions. , 2021, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.
[5] V. Patel,et al. Preventing medication-related osteonecrosis of the jaw , 2019, BMJ.
[6] R. Friedrich,et al. The effect of bisphosphonate medication on orthodontics and orthognathic surgery in patients with osteogenesis imperfecta , 2019, GMS Interdisciplinary plastic and reconstructive surgery DGPW.
[7] G. Warfvinge,et al. Prevalence, initiating factor, and treatment outcome of medication-related osteonecrosis of the jaw-a 4-year prospective study. , 2018, Oral surgery, oral medicine, oral pathology and oral radiology.
[8] M. Zandi,et al. Evaluation of mandibular fracture healing in rats under zoledronate therapy: A histologic study. , 2017, Injury.
[9] L. Mezzomo,et al. The risk of osteonecrosis on alveolar healing after tooth extraction and systemic administration of antiresorptive drugs in rodents: a systematic review. , 2017, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.
[10] F. Neukam,et al. Consultation with a specialized pain clinic reduces pain after oral and maxillofacial surgery. , 2017, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.
[11] T. Ettl,et al. Evaluation of surgical outcome and influencing risk factors in patients with medication-related osteonecrosis of the jaws. , 2016, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.
[12] M. Ehrenfeld,et al. Fluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw: A prospective cohort study. , 2016, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.
[13] L. Lima,et al. Bisphosphonate treatment and dental implants: A systematic review , 2016, Medicina oral, patologia oral y cirugia bucal.
[14] S. Pandian,et al. Effect of bisphosphonates on orthodontic tooth movement-an update. , 2015, Journal of clinical and diagnostic research : JCDR.
[15] B. Hohlweg-Majert,et al. Treatment perspectives for medication-related osteonecrosis of the jaw (MRONJ). , 2015, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.
[16] T. Dodson,et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. , 2014, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[17] W. Zemann,et al. The phosphorous necrosis of the jaws and what can we learn from the past: a comparison of “phossy” and “bisphossy” jaw , 2014, Oral and Maxillofacial Surgery.
[18] C. Scully,et al. Tooth extractions in intravenous bisphosphonate-treated patients: a refined protocol. , 2013, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[19] S. Belknap,et al. Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project. , 2013, The Journal of bone and joint surgery. American volume.
[20] Katsu Takahashi,et al. Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: a cohort study. , 2012, International journal of oral and maxillofacial surgery.
[21] M. Mozzati,et al. Tooth extraction in patients on zoledronic acid therapy. , 2012, Oral oncology.
[22] R. F. Sirandoni,et al. Orthognathic surgery in a patient with osteogenesis imperfecta: a case study , 2011 .
[23] A. Rosén,et al. Orthognathic bimaxillary surgery in two patients with osteogenesis imperfecta and a review of the literature. , 2011, International journal of oral and maxillofacial surgery.
[24] M. Broome,et al. [The return of phossy jaw?]. , 2008, Revue de Stomatologie et de Chirurgie Maxillo-Faciale.
[25] R. Marx. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. , 2003, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[26] S. Kates,et al. How do bisphosphonates affect fracture healing? , 2016, Injury.
[27] K. Purmal,et al. Oral Bisphosphonate and Orthognathic Surgery: A Case Report and Literature Review , 2014 .